BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17627892)

  • 1. Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients.
    Frisullo G; Nociti V; Iorio R; Katia Patanella A; Bianco A; Caggiula M; Sancricca C; Tonali PA; Mirabella M; Batocchi AP
    Clin Immunol; 2007 Sep; 124(3):284-93. PubMed ID: 17627892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.
    Frisullo G; Angelucci F; Caggiula M; Nociti V; Iorio R; Patanella AK; Sancricca C; Mirabella M; Tonali PA; Batocchi AP
    J Neurosci Res; 2006 Oct; 84(5):1027-36. PubMed ID: 16865709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+T-bet+, CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment.
    Frisullo G; Iorio R; Plantone D; Marti A; Nociti V; Patanella AK; Batocchi AP
    Mult Scler; 2011 May; 17(5):556-66. PubMed ID: 21177324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis.
    Iorio R; Frisullo G; Nociti V; Patanella KA; Bianco A; Marti A; Mirabella M; Tonali PA; Batocchi AP
    Clin Immunol; 2009 Apr; 131(1):70-83. PubMed ID: 19097824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy.
    Madia F; Frisullo G; Nociti V; Conte A; Luigetti M; Del Grande A; Patanella AK; Iorio R; Tonali PA; Batocchi AP; Sabatelli M
    J Peripher Nerv Syst; 2009 Jun; 14(2):107-17. PubMed ID: 19691533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease.
    Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Cammarota G; Mirabella M; Attilio Tonali P; Batocchi AP
    Hum Immunol; 2008 Dec; 69(12):837-9. PubMed ID: 18940217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive effect of glucocorticoids on TNF-alpha production is associated with their clinical effect in multiple sclerosis.
    van Winsen LM; Polman CH; Dijkstra CD; Tilders FJ; Uitdehaag BM
    Mult Scler; 2010 Apr; 16(4):500-2. PubMed ID: 20086025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b.
    Jensen MA; Yanowitch RN; Reder AT; White DM; Arnason BG
    Mult Scler; 2010 Jan; 16(1):30-8. PubMed ID: 20007427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of regulatory CD8+ T-lymphocytes and fall of activated CD8+ T-lymphocytes after i.v. methyl-prednisolone for multiple sclerosis relapse.
    Aristimuño C; Navarro J; de Andrés C; Martínez-Ginés L; Giménez-Roldán S; Fernández-Cruz E; Sánchez-Ramón S
    J Neuroimmunol; 2008 Nov; 204(1-2):131-5. PubMed ID: 18835045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment.
    Lindquist S; Hassinger S; Lindquist JA; Sailer M
    Mult Scler; 2011 Jul; 17(7):851-66. PubMed ID: 21561957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-beta inhibits human Th17 cell differentiation.
    Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
    J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
    Chen M; Chen G; Nie H; Zhang X; Niu X; Zang YC; Skinner SM; Zhang JZ; Killian JM; Hong J
    Eur J Immunol; 2009 Sep; 39(9):2525-36. PubMed ID: 19670379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreases in interleukin-4 secretion by invariant CD4(-)CD8(-)V alpha 24J alpha Q T cells in peripheral blood of patientswith relapsing-remitting multiple sclerosis.
    Gausling R; Trollmo C; Hafler DA
    Clin Immunol; 2001 Jan; 98(1):11-7. PubMed ID: 11141321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD95/Fas expression on peripheral blood T lymphocytes in patients with multiple sclerosis: effect of high-dose methylprednisolone therapy.
    Petelin Z; Brinar V; Petravic D; Zurak N; Dubravcic K; Batinic D
    Clin Neurol Neurosurg; 2004 Jun; 106(3):259-62. PubMed ID: 15177780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 immune response in progressive multiple sclerosis.
    Frisullo G; Plantone D; Marti A; Iorio R; Damato V; Nociti V; Patanella AK; Bianco A; Batocchi AP
    J Neuroimmunol; 2012 Aug; 249(1-2):112-6. PubMed ID: 22613700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of high-dose methylprednisolone treatment on CCR5 expression on blood cells in MS exacerbation.
    Elovaara I; Kuusisto H; Paalavuo R; Särkijärvi S; Lehtimäki T; Huhtala H; Vilpo J
    Acta Neurol Scand; 2006 Mar; 113(3):163-6. PubMed ID: 16441245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes.
    Leussink VI; Jung S; Merschdorf U; Toyka KV; Gold R
    Arch Neurol; 2001 Jan; 58(1):91-7. PubMed ID: 11176941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis: chemokine receptor expression on circulating lymphocytes in correlation with radiographic measures of tissue injury.
    Fox RJ; Kivisakk P; Fisher E; Tucky B; Lee JC; Rudick RA; Ransohoff RM
    Mult Scler; 2008 Sep; 14(8):1036-43. PubMed ID: 18701575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis.
    Miyazaki Y; Iwabuchi K; Kikuchi S; Fukazawa T; Niino M; Hirotani M; Sasaki H; Onoé K
    Mult Scler; 2008 Sep; 14(8):1044-55. PubMed ID: 18573819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8(+) T cells in facioscapulohumeral muscular dystrophy patients with inflammatory features at muscle MRI.
    Frisullo G; Frusciante R; Nociti V; Tasca G; Renna R; Iorio R; Patanella AK; Iannaccone E; Marti A; Rossi M; Bianco A; Monforte M; Tonali PA; Mirabella M; Batocchi AP; Ricci E
    J Clin Immunol; 2011 Apr; 31(2):155-66. PubMed ID: 21063901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.